Valuation: Spineway

Market Cap 33.31L 36.71L 30.78L 27.79L 52.37L 35Cr 54.19L 3.7Cr 1.47Cr 18Cr 1.38Cr 1.35Cr 59Cr P/E 2026 *
-1.49x
P/E 2027 * -1.56x
Enterprise Value 59.31L 65.36L 54.82L 49.48L 93.25L 62Cr 96.5L 6.58Cr 2.61Cr 33Cr 2.45Cr 2.4Cr 104.37Cr EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.74x
Free-Float
9.65%
Yield 2026 *
-
Yield 2027 * -
1 week-8.14%
Current month+7.70%
1 month-20.86%
3 months-29.97%
6 months-38.44%
Current year-38.36%
1 week 0.09
Extreme 0.092
0.1
1 month 0.08
Extreme 0.0816
0.12
Current year 0.08
Extreme 0.0816
0.21
1 year 0.08
Extreme 0.0816
0.21
3 years 0.07
Extreme 0.073
64.2
5 years 0.07
Extreme 0.073
96,000
10 years 0.07
Extreme 0.073
40,56,00,000
Manager TitleAgeSince
Chief Executive Officer 66 28/09/2005
Director of Finance/CFO - 01/11/2024
Director TitleAgeSince
Chairman 66 28/09/2005
Director/Board Member 48 13/10/2017
Director/Board Member 46 26/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-8.14%-41.44%-99.85% 20.63L
+1.18%-4.47%-15.76%+15.48% 19TCr
+1.85%-1.89%+7.36%+45.53% 12TCr
-0.88%-7.59%-15.71%+13.16% 12TCr
+1.36%-5.00%-43.14%+4.26% 9.14TCr
+2.96%+5.70%-1.21%+81.72% 6.67TCr
+1.08%+2.10%+13.49%-7.08% 5.88TCr
+0.89%+5.00%-1.31%+64.26% 5.5TCr
-0.68%-0.62%-2.41%+56.27% 4.99TCr
-1.28%-0.73% - - 3.51TCr
Average +0.35%-2.59%-11.12%+19.31% 8TCr
Weighted average by Cap. +0.42%-3.37%-9.75%+29.11%

Financials

2026 *2027 *
Net sales 1.32Cr 1.45Cr 1.22Cr 1.1Cr 2.08Cr 137.14Cr 2.15Cr 15Cr 5.81Cr 73Cr 5.46Cr 5.34Cr 232.3Cr 1.45Cr 1.6Cr 1.34Cr 1.21Cr 2.28Cr 150.64Cr 2.36Cr 16Cr 6.38Cr 80Cr 6Cr 5.87Cr 255.18Cr
Net income -25L -27.55L -23.11L -20.86L -39.31L -26Cr -40.68L -2.78Cr -1.1Cr -14Cr -1.03Cr -1.01Cr -44Cr -25L -27.55L -23.11L -20.86L -39.31L -26Cr -40.68L -2.78Cr -1.1Cr -14Cr -1.03Cr -1.01Cr -44Cr
Net Debt 26L 28.65L 24.03L 21.69L 40.88L 27Cr 42.31L 2.89Cr 1.14Cr 14Cr 1.08Cr 1.05Cr 46Cr 74L 81.56L 68.4L 61.74L 1.16Cr 77Cr 1.2Cr 8.22Cr 3.26Cr 41Cr 3.06Cr 3Cr 130.23Cr
Projected Income Statement - Annual - Spineway
Logo Spineway
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc. Net sales are distributed geographically as follows: France (24.4%), Europe (16.9%), Latin America (34.3%), Asia (18.2%) and the Middle East and Africa (6.2%).
Employees
43
Date Price Change Volume
13/26/13 €0.0937 0.00% 9,434
12/26/12 €0.0937 +0.32% 33,815
11/26/11 €0.0934 0.00% 12,877
10/26/10 €0.0934 -1.68% 15,454
09/26/09 €0.0950 0.00% 24,831
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0937EUR
Average target price
0.2100EUR
Spread / Average Target
+124.12%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Spineway
  1. Stock Market
  2. Stocks
  3. ALSPW Stock